共 50 条
- [1] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic LeukemiaBLOOD, 2019, 134Yang, Junfang论文数: 0 引用数: 0 h-index: 0机构: Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaJiang, Pengfei论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaZhang, Xian论文数: 0 引用数: 0 h-index: 0机构: Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaZhu, Xiaobin论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaDong, Qi论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaHe, Jiaping论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaLin, Nanjing论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaWang, Zhenguang论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaCai, Songbai论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaYe, Xun论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaSu, Yunchao论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaLi, Wenqian论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaLi, Jingjing论文数: 0 引用数: 0 h-index: 0机构: Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaYu, Ziyao论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaHe, Jiujiang论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaXu, Li论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaSong, Dan论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaCao, Wei论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotech Co Ltd, Shanghai, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R ChinaLu, Peihua论文数: 0 引用数: 0 h-index: 0机构: Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China
- [2] Meta-analysis of response rates to first-line salvage treatment after CAR-T therapy failure in large B-cell lymphoma patientsEXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 389 - 397论文数: 引用数: h-index:机构:Bilicki, Dominik论文数: 0 引用数: 0 h-index: 0机构: Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, 1A Banacha Str, PL-02097 Warsaw, Poland Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, 1A Banacha Str, PL-02097 Warsaw, PolandBasak, Grzegorz Wladyslaw论文数: 0 引用数: 0 h-index: 0机构: Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, 1A Banacha Str, PL-02097 Warsaw, Poland Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, 1A Banacha Str, PL-02097 Warsaw, Poland
- [3] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapyONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037Zhu, Haibo论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaDeng, Haobin论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ, Cent Clin Coll 1, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaMu, Juan论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaLyu, Cuicui论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaJiang, Yanyu论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaDeng, Qi论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China
- [4] The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemiaFRONTIERS IN IMMUNOLOGY, 2024, 15Ma, Yuhan论文数: 0 引用数: 0 h-index: 0机构: Suqian First Hosp, Dept Hematol, Suqian, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaZhou, Hongyuan论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaZhang, Jiaoli论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Rehabil, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaZhang, Qing论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaLi, Yujie论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaXie, Ruiyang论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaZhang, Bingpei论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaShen, Ziyuan论文数: 0 引用数: 0 h-index: 0机构: Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaLi, Ping论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaLiang, Aibin论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaZhou, Keshu论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaHan, Lu论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaHu, Yongxian论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Hematol, Hangzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaXu, Kailin论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaSang, Wei论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R ChinaWang, Xiangmin论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Peoples R China Suqian First Hosp, Dept Hematol, Suqian, Peoples R China
- [5] A Feasibility and Safety Study of Non-Viral Genome Targeting Anti-CD19 CAR-T in Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaBLOOD, 2020, 136Wang, Yi论文数: 0 引用数: 0 h-index: 0Wang, Hui论文数: 0 引用数: 0 h-index: 0Gao, Ying论文数: 0 引用数: 0 h-index: 0Zhang, Ding论文数: 0 引用数: 0 h-index: 0Zheng, Yan论文数: 0 引用数: 0 h-index: 0Hu, Xingxing论文数: 0 引用数: 0 h-index: 0Gao, Qiuying论文数: 0 引用数: 0 h-index: 0Peng, Zuohan论文数: 0 引用数: 0 h-index: 0Li, Le论文数: 0 引用数: 0 h-index: 0Niu, Ben论文数: 0 引用数: 0 h-index: 0Hou, Limin论文数: 0 引用数: 0 h-index: 0Wang, Ling论文数: 0 引用数: 0 h-index: 0Zhang, Weihua论文数: 0 引用数: 0 h-index: 0Zhang, Yi论文数: 0 引用数: 0 h-index: 0Ru, Xingli论文数: 0 引用数: 0 h-index: 0
- [6] Anti-CD19 CAR T-cell therapy post antibody treatment in adult patients with relapsed/refractory precursor B-acute lymphoblastic leukemiaBONE MARROW TRANSPLANTATION, 2019, 54 : 517 - 518Danylesko, Ivetta论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelBesser, Michal论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ella Lemelbaum Inst Immuno Oncol, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelJacoby, Elad论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr Tel Hashomer, Edmond & Lily Safra Childrens Hosp, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelItzhaki, Orit论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ella Lemelbaum Inst Immuno Oncol, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelShem-Tov, Noga论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelYerushalmi, Ronit论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelToren, Amos论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr Tel Hashomer, Edmond & Lily Safra Childrens Hosp, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelShimoni, Avichai论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelNagler, Arnon论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, IsraelAvigdor, Abraham论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel
- [7] CD19-specific car-t cells for the treatment of cns chloromas in children with relapsed/refractory b-cell acute lymphoblastic leukemiaBONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 137 - 138Shahid, S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USACancio, M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAHaque, S. S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAKhakoo, Y.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAMcWilliams, E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASantomasso, B. D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAScaradavou, A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASpitzer, B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAWolden, S. L.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USABoelens, J. J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USACurran, K. J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
- [8] High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic LeukemiaBLOOD, 2023, 142Fried, Shalev论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelDanylesko, Ivetta论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelMarcus, Ronit论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelItzhaki, Orit论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Ella Lemelbaum Inst Immuno Oncol, Tel Hashomer, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelYerushalmi, Ronit论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelShem-Tov, Noga论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelSdayoor, Inbal论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelShouval, Roni论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Adult BMT Serv, New York, NY USA Weill Cornell Med Coll, Dept Med, New York, NY USA Tel Aviv Univ, Fac Med, Tel Aviv, IsraelJacoby, Elad论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Safra Childrens Hosp, Dept Pediat Hematol Oncol, Sheba Med Ctr, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelKedmi, Meirav论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelNagler, Arnon论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelShimoni, Avichai论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, IsraelAvigdor, Abraham论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Fac Med, Tel Aviv, Israel Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel Tel Aviv Univ, Fac Med, Tel Aviv, Israel
- [9] Efficacy and Safety of Children With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia After Anti-CD19 CAR T-Cell Therapy Without Bridging TransplantationCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (06): : 392 - 399.e5Shang, Qianwen论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R ChinaXue, Lian论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R ChinaLu, Aidong论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R ChinaJia, Yueping论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R ChinaZuo, YingXi论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R ChinaZeng, Huimin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R ChinaZhang, Leping论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, Dept Pediat, 11,Xizhimen South St, Beijing 100044, Peoples R China
- [10] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T TherapyBLOOD, 2020, 136Yu, Xinjian论文数: 0 引用数: 0 h-index: 0Li, Pan论文数: 0 引用数: 0 h-index: 0Feng, Heyuan论文数: 0 引用数: 0 h-index: 0Kang, Jian论文数: 0 引用数: 0 h-index: 0Zheng, Xichang论文数: 0 引用数: 0 h-index: 0Zhang, Yunmei论文数: 0 引用数: 0 h-index: 0Yang, Wenhong论文数: 0 引用数: 0 h-index: 0Wu, Tong论文数: 0 引用数: 0 h-index: 0Liu, Shuangyou论文数: 0 引用数: 0 h-index: 0